HORIZON PHARMA INVT LTD's ticker is and the CUSIP is 44052TAB7. A total of 27 filers reported holding HORIZON PHARMA INVT LTD in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $3,053,000 | -47.2% | 2,655,000 | -39.4% | 0.60% | -0.2% |
| Q4 2019 | $5,784,000 | +13.5% | 4,380,000 | 0.0% | 0.60% | +38.9% |
| Q3 2019 | $5,098,000 | +88.2% | 4,380,000 | +79.1% | 0.43% | +73.0% |
| Q2 2019 | $2,709,000 | +30.2% | 2,445,000 | +33.6% | 0.25% | +33.3% |
| Q1 2019 | $2,081,000 | -70.0% | 1,830,000 | -73.7% | 0.19% | -75.0% |
| Q4 2018 | $6,934,000 | +10.6% | 6,965,000 | +11.7% | 0.74% | +48.1% |
| Q3 2018 | $6,272,000 | -24.1% | 6,235,000 | -27.8% | 0.50% | -13.4% |
| Q2 2018 | $8,264,000 | +10.8% | 8,635,000 | +6.1% | 0.58% | +9.0% |
| Q1 2018 | $7,460,000 | -48.8% | 8,135,000 | -48.1% | 0.53% | +10.8% |
| Q4 2017 | $14,574,000 | +106.0% | 15,670,000 | +100.0% | 0.48% | -1.6% |
| Q3 2017 | $7,076,000 | +4.8% | 7,835,000 | 0.0% | 0.49% | +2.5% |
| Q2 2017 | $6,753,000 | -33.1% | 7,835,000 | -29.3% | 0.48% | -32.9% |
| Q1 2017 | $10,087,000 | -4.4% | 11,085,000 | 0.0% | 0.71% | -11.0% |
| Q4 2016 | $10,546,000 | -1.6% | 11,085,000 | 0.0% | 0.80% | +12.2% |
| Q3 2016 | $10,718,000 | +32.8% | 11,085,000 | +24.5% | 0.71% | +27.1% |
| Q2 2016 | $8,070,000 | +3.7% | 8,905,000 | -2.5% | 0.56% | -1.6% |
| Q1 2016 | $7,782,000 | – | 9,135,000 | – | 0.57% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|